Home// - CGRP receptor-blockade Treatment
Are you sure you want to exit?
Any unsave changes will be lost.
CGRP receptor-blockade Treatment
BioHaven
Category
Laboratory
Country
United States of America (USA), North America
Description
Biohaven begins a clinical trial will assess the potential benefits of CGRP receptor-blockade in mitigating an excessive immune response which in some cases can be fatal in COVID-19